Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular genetics of primary open-angle glaucoma. | Indian J Ophthalmol | 2023 | 37203025 | PubTator, text mining | PubMed |
| Intragenic FOXC1 deletion in a Vietnamese child with Axenfeld-Rieger syndrome: case report and review of literature. | Clin Dysmorphol | 2023 | 37195356 | PubTator, text mining | PubMed |
| The single-cell and spatial transcriptional landscape of human gastrulation and early brain development. | Cell Stem Cell | 2023 | 37192616 | PubTator, text mining | PubMed |
| Bioinformatics Approach to Identify the Influences of COVID-19 on Ischemic Stroke. | Biochem Genet | 2023 | 37184686 | PubTator, text mining | PubMed |
| Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations. | Cancer Med | 2023 | 37184160 | PubTator, text mining | PubMed |
| Gut Microbiome and Small RNA Integrative-Omic Perspective of Meconium and Milk-FED Infant Stool Samples. | Int J Mol Sci | 2023 | 37175775 | PubTator, text mining | PubMed |
| Genetic considerations in cerebral small vessel diseases. | Front Neurol | 2023 | 37168667 | PubTator, text mining | PubMed |
| The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer. | Breast Cancer Res Treat | 2023 | 37160814 | PubTator, text mining | PubMed |
| Bioinformatics approach to analyse COVID-19 biomarkers accountable for generation of intracranial aneurysm in COVID-19 patients. | Inform Med Unlocked | 2023 | 37159621 | PubTator, text mining | PubMed |
| Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients. | Ann Surg Oncol | 2023 | 37154970 | PubTator, text mining | PubMed |
| Endothelial FOXC1 and FOXC2 promote intestinal regeneration after ischemia-reperfusion injury. | EMBO Rep | 2023 | 37154714 | PubTator, text mining | PubMed |
| Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma. | Nat Commun | 2023 | 37142597 | PubTator, text mining | PubMed |
| Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia. | Front Oncol | 2023 | 37091144 | PubTator, text mining | PubMed |
| Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice. | Front Pharmacol | 2023 | 37089959 | PubTator, text mining | PubMed |
| The pathogenetic influence of smoking on SARS-CoV-2 infection: Integrative transcriptome and regulomics analysis of lung epithelial cells. | Comput Biol Med | 2023 | 37084641 | PubTator, text mining | PubMed |
| Identification and characterization of bone/cartilage-associated signatures in common fibrotic skin diseases. | Front Genet | 2023 | 37082197 | PubTator, text mining | PubMed |
| Newly discovered mechanisms that mediate tumorigenesis and tumour progression: circRNA-encoded proteins. | J Cell Mol Med | 2023 | 37070530 | PubTator, text mining | PubMed |
| High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer. | Breast Cancer Res Treat | 2023 | 37061618 | PubTator, text mining | PubMed |
| Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. | Cancer Metastasis Rev | 2023 | 37059907 | PubTator, text mining | PubMed |
| Correction: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway. | Genome Med | 2023 | 37046351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=25